J&J's Suponcic decamps for Kantar

Kantar Health said it hired Susan Suponcic, PhD, as SVP of global market access. In her new role, Suponcic will lead a global team assisting pharma clients in incorporating, substantiating and implementing market access initiatives, according to a company statement.
Suponcic has more than 13 years of market access experience in both industry and consulting. She joins Kantar Health from Johnson & Johnson (J&J), where she held strategic roles in both pricing and health economics, led teams that carried out global launches and helped shape the external environment to focus on the value of pharmaceutical innovation, Kantar said.
Prior to J&J, Suponcic worked on the consulting side, leading IMS Health's pharma pricing consulting practice.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.